Overview
Tosan Fregene is a Hematologist Oncology specialist and a Palliative Medicine provider in Oak Park, Michigan. Dr. Fregene is rated as an Advanced provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Angiosarcoma, Anemia, Paget Disease of the Breast, Bone Marrow Aspiration, and Endoscopy. Dr. Fregene is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Regents Of The University Of Michigan
Norah Henry is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Henry is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Henry is currently accepting new patients.
Regents Of The University Of Michigan
Aki Morikawa is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Morikawa is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is currently accepting new patients.
Regents Of The University Of Michigan
Sofia Merajver is an Oncologist in Ann Arbor, Michigan. Dr. Merajver is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma. Dr. Merajver is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaDr. Fregene isDistinguished. Learn about Anemia.
- AngiosarcomaDr. Fregene isDistinguished. Learn about Angiosarcoma.
- Paget Disease of the BreastDr. Fregene isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Breast CancerDr. Fregene isAdvanced. Learn about Breast Cancer.
- Colorectal CancerDr. Fregene isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Fregene isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Fregene isAdvanced. Learn about Familial Pancreatic Cancer.
- Familial Prostate CancerDr. Fregene isAdvanced. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Fregene isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Fregene isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Fregene isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Ampullary CancerDr. Fregene isExperienced. Learn about Ampullary Cancer.
- B-Cell LymphomaDr. Fregene isExperienced. Learn about B-Cell Lymphoma.
- Bladder CancerDr. Fregene isExperienced. Learn about Bladder Cancer.
- Blood ClotsDr. Fregene isExperienced. Learn about Blood Clots.